Four notes:
1. Traders told the publication the spine device companies held early discussions about a potential deal.
2. In February 2019, it was reported that Smith+Nephew held talks with NuVasive to acquire the company in a deal exceeding $3 billion, but nothing came to fruition.
3. NuVasive’s current market cap is $2.9 billion and its short interest is 7.7 percent, according to Seeking Alpha.
4. In the third quarter, NuVasive posted $270.8 million in net sales, an 8.3 percent decrease from the same period in 2020. Globus Medical posted third-quarter net sales of $229.7 million, a 6.3 percent increase compared with the third quarter of 2020.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
